Theseus Pharmaceuticals Performance
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Theseus Pharmaceuticals are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Theseus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Theseus Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 115.9 M |
Theseus |
Theseus Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest (100.00) in Theseus Pharmaceuticals on December 25, 2024 and sell it today you would earn a total of 100.00 from holding Theseus Pharmaceuticals or generate -100.0% return on investment over 90 days. Theseus Pharmaceuticals is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Theseus, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Theseus Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Theseus Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Theseus Pharmaceuticals, and traders can use it to determine the average amount a Theseus Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| THRX |
Based on monthly moving average Theseus Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Theseus Pharmaceuticals by adding Theseus Pharmaceuticals to a well-diversified portfolio.
Theseus Pharmaceuticals Fundamentals Growth
Theseus Stock prices reflect investors' perceptions of the future prospects and financial health of Theseus Pharmaceuticals, and Theseus Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Theseus Stock performance.
| Return On Equity | -0.26 | |||
| Return On Asset | -0.18 | |||
| Current Valuation | (20.19 M) | |||
| Shares Outstanding | 44.65 M | |||
| Price To Earning | 737.67 X | |||
| Price To Book | 0.81 X | |||
| EBITDA | (66.44 M) | |||
| Cash And Equivalents | 212.43 M | |||
| Cash Per Share | 5.55 X | |||
| Total Debt | 3.98 M | |||
| Debt To Equity | 0.02 % | |||
| Book Value Per Share | 5.17 X | |||
| Cash Flow From Operations | (49.63 M) | |||
| Earnings Per Share | (1.34) X | |||
| Total Asset | 222.45 M | |||
| Retained Earnings | (112.19 M) | |||
| Current Asset | 223.75 M | |||
| Current Liabilities | 11.28 M | |||
Things to note about Theseus Pharmaceuticals performance evaluation
Checking the ongoing alerts about Theseus Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Theseus Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Theseus Pharmaceuticals is not yet fully synchronised with the market data | |
| Theseus Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Theseus Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (56.61 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Theseus Pharmaceuticals currently holds about 212.43 M in cash with (49.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.55. | |
| Over 93.0% of the company shares are owned by institutional investors |
- Analyzing Theseus Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Theseus Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Theseus Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Theseus Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Theseus Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Theseus Pharmaceuticals' stock. These opinions can provide insight into Theseus Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Theseus Stock
If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |